0000001 001  NULL    **6;0;START              
0000001 002  -----   -----                    
0000002 010  NP1     SAN                      Z2[i4.2.1 Z3c[i4.2.1 Z2[i2.2.1 Z2/S2mf Z2[i3.2.1 Z3c[i3.2.1 Z1mf[i1.2.1 Z3c[i1.2.1 
0000002 020  NP1     DIEGO                    Z2[i4.2.2 Z3c[i4.2.2 Z2[i2.2.2 Z1m Z2[i3.2.2 Z3c[i3.2.2 Z1mf[i1.2.2 Z3c[i1.2.2 
0000002 030  JJ      d--                      Z99 
0000002 040  NN1     Ajinomoto                Z99 
0000002 050  NN1     Co.                      I2.1/S5c 
0000002 051  ,       ,                        
0000002 060  JJ      Inc                      I2.1 
0000002 061  .       .                        
0000002 062  (       (                        
0000002 063  NULL    <quote>                  
0000002 064  -----   -----                    
0000002 065  "       "                        
0000002 070  NP1     Ajinomoto                Z1mf[i5.2.1 Z3c[i5.2.1 
0000002 080  NP1     Co                       Z1mf[i5.2.2 Z3c[i5.2.2 
0000002 081  .       .                        
0000002 082  "       "                        
0000002 083  NULL    </quote>                 
0000002 084  -----   -----                    
0000002 085  ;       ;                        
0000002 090  NP1     TYO                      Z99 
0000002 091  :       :                        
0000002 100  MC      2802                     N1 T1.2 T3 T1.3 N3.2 
0000002 101  )       )                        
0000002 110  CC      and                      Z5 
0000002 120  NP1     Althea                   Z99 
0000002 130  NN2     Technologies             Y1 
0000002 131  ,       ,                        
0000002 140  JJ      Inc                      I2.1 
0000002 141  .       .                        
0000002 142  (       (                        
0000002 143  NULL    <quote>                  
0000002 144  -----   -----                    
0000002 145  "       "                        
0000002 150  NP1     Althea                   Z99 
0000002 160  NN2     Technologies             Y1 
0000002 161  "       "                        
0000002 162  NULL    </quote>                 
0000002 163  -----   -----                    
0000002 164  )       )                        
0000002 165  ,       ,                        
0000002 170  VH0     have                     Z5 A9+ A2.2 S4 
0000002 180  VVN     completed                T2- Q1.2 
0000002 190  AT      the                      Z5 
0000002 200  RR      previously               N4 
0000002 210  VVN     announced                Q2.2 
0000002 220  NN1     acquisition              A9+ 
0000002 230  IO      of                       Z5 
0000002 240  NP1     Althea                   Z99 
0000002 250  NN2     Technologies             Y1 
0000002 251  ,       ,                        
0000002 260  AT1     a                        Z5 
0000002 270  JJ      leading                  S7.1+ A11.1+ A2.2 M2 A1.1.1 
0000002 280  NN1     provider                 A9-/S2mf 
0000002 290  IO      of                       Z5 
0000002 300  JJ      biopharmaceutical        Z99 
0000002 310  NN1     development              A2.1+ A5.1+/A2.1 H1 
0000002 320  CC      and                      Z5 
0000002 330  NN1     manufacturing            A1.1.1 
0000002 340  NN2     services                 S8+ S7.1- A1.1.1 S9 G3@ G2.1@ M3/M7@ 
0000002 341  .       .                        
0000003 001  -----   -----                    
0000004 001  (       (                        
0000004 010  NN1     Logo                     C1/Q1.1 Q1.2 
0000004 011  :       :                        
0000004 020  NNU     http                     I1 
0000004 021  :       :                        
0000004 030  NN1     **49;7;TOOLONG           Z99 
0000004 031  )       )                        
0000006 010  NP1     Ajinomoto                Z99 
0000006 020  VVD     acquired                 A9+ 
0000006 030  DB      all                      N5.1+ 
0000006 040  AT      the                      Z5 
0000006 050  NN1     capital                  I1.1 M7/G1.1 Q1.2 
0000006 060  NN1     stock                    A9+ F1 S4 O2 I1.1 
0000006 070  IO      of                       Z5 
0000006 080  NP1     Althea                   Z99 
0000006 090  II      at                       Z5 
0000006 100  VVG     closing                  A1.1.1 A10- T2- 
0000006 110  IF      for                      Z5 
0000006 120  AT1     a                        Z5 
0000006 130  NN1     purchase                 I2.2 
0000006 140  NN1     price                    I1.3 
0000006 150  IO      of                       Z5 
0000006 160  RR      approximately            A13.4 
0000006 170  NNU     $175                     Z99/H1c[i6.2.1 
0000006 180  NNO     million                  Z99/H1c[i6.2.2 N1 I1 
0000006 190  NNU2    dollars                  I1 
0000006 191  (       (                        
0000006 200  NP1     USD                      Z99 
0000006 201  )       )                        
0000006 202  .       .                        
0000006 203  -----   -----                    
0000006 210  NN1     Althea                   Z99 
0000006 220  VM      will                     T1.1.3 
0000006 230  VVI     become                   A2.1+ O4.2+ 
0000006 240  AT1     a                        Z5 
0000006 250  RR      fully                    A13.2 N5.1+ 
0000006 260  JJ      consolidated             A7+/A2.1 S5+ 
0000006 270  NN1     subsidiary               A11.1- S5+ 
0000006 280  IO      of                       Z5 
0000006 290  NP1     Ajinomoto                Z1mf[i7.2.1 Z3c[i7.2.1 
0000006 300  NP1     Co.                      Z1mf[i7.2.2 Z3c[i7.2.2 
0000006 301  ,       ,                        
0000006 310  JJ      Inc.                     I2.1 
0000006 320  NN1     operating                A1.1.1 B3 
0000006 330  II      under                    Z5 
0000006 340  AT      the                      Z5 
0000006 350  NN1     company                  I2.1/S5+c S5+c G3/S5+c S3.1 K4/S5+c 
0000006 360  NN1     name                     Q2.2 
0000006 370  NP1     Ajinomoto                Z1mf[i8.2.1 Z3c[i8.2.1 
0000006 380  NP1     Althea                   Z1mf[i8.2.2 Z3c[i8.2.2 
0000006 381  ,       ,                        
0000006 390  JJ      Inc                      I2.1 
0000006 391  .       .                        
0000007 001  -----   -----                    
0000008 010  II      About                    Z5 
0000008 020  NP1     Ajinomoto                Z1mf[i9.2.1 Z3c[i9.2.1 
0000008 030  NP1     Co                       Z1mf[i9.2.2 Z3c[i9.2.2 
0000008 031  .       .                        
0000009 001  -----   -----                    
0000010 010  NP1@    Ajinomoto                Z1mf[i10.2.1 Z3c[i10.2.1 
0000010 020  NP1     Co.                      Z1mf[i10.2.2 Z3c[i10.2.2 
0000010 030  VBZ     is                       A3+ Z5 
0000010 040  AT1     a                        Z5 
0000010 050  JJ      global                   W3 M7 A1.8+ O4.4 
0000010 060  NN1     manufacturer             A1.1.1/S2mfc 
0000010 070  IO      of                       Z5 
0000010 080  JJ      high-quality             A5.1+ 
0000010 090  NN2     seasonings               F1 
0000010 091  ,       ,                        
0000010 100  JJ      processed                O4.1 
0000010 110  NN2     foods                    F1 
0000010 111  ,       ,                        
0000010 120  NN2     beverages                F2 
0000010 121  ,       ,                        
0000010 130  NN1     amino                    O1[i11.2.1 B1 
0000010 140  NN2     acids                    O1[i11.2.2 O1 K2 F3% 
0000010 141  ,       ,                        
0000010 150  NN2     pharmaceuticals          B3 
0000010 160  CC      and                      Z5 
0000010 170  NN1     specialty                A4.2+ 
0000010 180  NN2     chemicals                O1 
0000010 181  .       .                        
0000010 182  -----   -----                    
0000010 190  IF      For                      T1.3+[i12.3.1 Z5 
0000010 200  DA2     many                     T1.3+[i12.3.2 N5+ 
0000010 210  NNT2    decades                  T1.3+[i12.3.3 T1.3 
0000010 220  NP1     Ajinomoto                Z1mf[i13.2.1 Z3c[i13.2.1 
0000010 230  NP1     Co.                      Z1mf[i13.2.2 Z3c[i13.2.2 
0000010 240  VHZ     has                      Z5 A9+ A2.2 S4 
0000010 250  VVN     contributed              A9- A2.2 S1.1.3+ 
0000010 260  II      to                       Z5 
0000010 270  NN1     food                     F1 
0000010 280  NN1     culture                  C1 S1.1.1 S5+ L1 
0000010 290  CC      and                      Z5 
0000010 300  JJ      human                    S2 S1.2.1+ 
0000010 310  NN1     health                   B2 X9.2 
0000010 320  II      through                  Z5 
0000010 330  JJ      wide-ranging             A6.3+/A2.2 
0000010 340  NN1     application              Q1.2 A1.5.1 Y2 X5.1+ A1.1.1 
0000010 350  IO      of                       Z5 
0000010 360  NN1     amino                    O1[i14.2.1 B1 
0000010 370  NN1     acid                     O1[i14.2.2 O1 K2 F3% 
0000010 380  NN2     technologies             Y1 
0000010 381  .       .                        
0000010 382  -----   -----                    
0000010 390  RT      Today                    T1.1.2 
0000010 391  ,       ,                        
0000010 400  AT      the                      Z5 
0000010 410  NN1     company                  I2.1/S5+c S5+c G3/S5+c S3.1 K4/S5+c 
0000010 420  VBZ     is                       Z5 A3+ 
0000010 430  VVG     becoming                 A2.1+ O4.2+ 
0000010 440  RR      increasingly             A13.3 
0000010 450  JJ      involved                 A1.8+ A12- X5.2+ 
0000010 460  IW      with                     Z5 
0000010 470  NN2     solutions                X4.2 O1.2 
0000010 480  IF      for                      Z5 
0000010 490  JJ      improved                 A5.1+/A2.1 
0000010 500  NN1     food                     F1 
0000010 510  NN2     resources                A9+ W3 
0000010 511  ,       ,                        
0000010 520  JJ      human                    S2 S1.2.1+ 
0000010 530  NN1     health                   B2 X9.2 
0000010 540  CC      and                      Z5 
0000010 550  JJ      global                   W3 M7 A1.8+ O4.4 
0000010 560  NN1     sustainability           T2++ 
0000010 561  .       .                        
0000010 562  -----   -----                    
0000010 570  VVN     Founded                  T2+ A2.2 A1.1.1 
0000010 580  II      in                       Z5 
0000010 590  MC      1909                     N1 T1.2 T3 T1.3 N3.2 
0000010 600  CC      and                      Z5 
0000010 610  RT      now                      T1.1.2 Z4 
0000010 620  VVG     operating                A1.1.1 B3 
0000010 630  II      in                       Z5 
0000010 640  MC      26                       N1 T1.2 T3 T1.3 N3.2 
0000010 650  NN2     countries                M7 
0000010 651  ,       ,                        
0000010 660  NP1     Ajinomoto                Z1mf[i15.2.1 Z3c[i15.2.1 
0000010 670  NP1     Co.                      Z1mf[i15.2.2 Z3c[i15.2.2 
0000010 680  VHD     had                      A9+ Z5 A2.2 S4 
0000010 690  JJ      net                      N5 
0000010 700  NN      sales                    I2.2 I2.2/I1.3- 
0000010 710  IO      of                       Z5 
0000010 720  NP1     JYP                      Z2[i16.2.1 Z1mf[i16.2.1 
0000010 730  MC      1,197.3                  Z2[i16.2.2 Z1mf[i16.2.2 N1 T1.2 T3 T1.3 N3.2 N1[i17.2.1 T1.3[i17.2.1 I1[i17.2.1 
0000010 740  NNO     billion                  N1 I1 N1[i17.2.2 T1.3[i17.2.2 I1[i17.2.2 
0000010 741  (       (                        
0000010 750  NP1     USD                      Z2[i18.2.1 Z1mf[i18.2.1 
0000010 760  MC      15.1                     Z2[i18.2.2 Z1mf[i18.2.2 N1 T1.2 T3 T1.3 N3.2 N1[i19.2.1 T1.3[i19.2.1 I1[i19.2.1 
0000010 770  NNO     billion                  N1 I1 N1[i19.2.2 T1.3[i19.2.2 I1[i19.2.2 
0000010 771  )       )                        
0000010 780  II      in                       Z5 
0000010 790  JJ      fiscal                   I1/G1.1 I1 
0000010 800  MC      2011                     N1 T1.2 T3 T1.3 N3.2 
0000010 801  .       .                        
0000010 802  -----   -----                    
0000010 810  IF      For                      Z5 
0000010 820  DAR     more                     N5++ 
0000010 830  II      about                    Z5 
0000010 840  NP1     Ajinomoto                Z1mf[i20.2.1 Z3c[i20.2.1 
0000010 850  NP1     Co                       Z1mf[i20.2.2 Z3c[i20.2.2 
0000010 851  .       .                        
0000010 852  -----   -----                    
0000010 853  (       (                        
0000010 860  NP1     TYO                      Z99 
0000010 861  :       :                        
0000010 870  MC      2802                     N1 T1.2 T3 T1.3 N3.2 
0000010 871  )       )                        
0000010 872  ,       ,                        
0000010 880  VV0     visit                    S1.1.1 M1 
0000010 890  NNU     www.ajinomoto.com        N3.3 N3.7 
0000010 891  .       .                        
0000011 001  -----   -----                    
0000012 010  II      About                    Z5 
0000012 020  NP1     Althea                   Z99 
0000012 030  NN2     Technologies             Y1 
0000014 010  NP1     Althea                   Z99 
0000014 020  NN2     Technologies             Y1 
0000014 030  VBZ     is                       A3+ Z5 
0000014 040  AT1     a                        Z5 
0000014 050  RR      fully                    A13.2 N5.1+ 
0000014 060  VVN     integrated               A1.8+ S5+ A2.2 N2% 
0000014 061  ,       ,                        
0000014 070  NN1     contract                 I2.1 G2.1 
0000014 080  NN1     development              A2.1+ A5.1+/A2.1 H1 
0000014 090  CC      and                      Z5 
0000014 100  NN1     manufacturing            A1.1.1 
0000014 110  NN1     organization             S5+c S7.1+ 
0000014 120  VVN     located                  M6 A10+ 
0000014 130  II      in                       Z5 
0000014 140  NP1     San                      Z2[i24.2.1 Z3c[i24.2.1 Z2[i22.2.1 Z2/S2mf Z2[i23.2.1 Z3c[i23.2.1 Z1mf[i21.2.1 Z3c[i21.2.1 
0000014 150  NP1     Diego                    Z2[i24.2.2 Z3c[i24.2.2 Z2[i22.2.2 Z1m Z2[i23.2.2 Z3c[i23.2.2 Z1mf[i21.2.2 Z3c[i21.2.2 
0000014 151  ,       ,                        
0000014 160  NP1@    CA                       A7+ 
0000014 170  VVG     providing                A9- 
0000014 180  JJ      clinical                 B3 S1.2.1- 
0000014 190  CC      and                      Z5 
0000014 200  JJ      commercial               I2.1 
0000014 210  NN1     product                  O2 A1.1.1 A2.2 N2% 
0000014 220  NN1     development              A2.1+ A5.1+/A2.1 H1 
0000014 230  NN2     services                 S8+ S7.1- A1.1.1 S9 G3@ G2.1@ M3/M7@ 
0000014 231  .       .                        
0000014 232  -----   -----                    
0000014 240  NN1     Althea                   Z99 
0000014 250  NN2     Technologies             Y1 
0000014 260  VVZ@    offers                   A9- Q2.2 
0000014 270  NNU     cGMP                     I1 
0000014 280  NN1     drug                     B3 F3 
0000014 290  NN1     product                  O2 A1.1.1 A2.2 N2% 
0000014 300  VVG     filling                  Q1.2[i25.2.1 S1.1.1[i25.2.1 A1.1.1[i25.2.1 A1.5.1+[i25.2.1 N5.1+ I3.1 Q1.2@ 
0000014 310  RP@     in                       Q1.2[i25.2.2 S1.1.1[i25.2.2 A1.1.1[i25.2.2 A1.5.1+[i25.2.2 M6 
0000014 320  RR      both                     Z5 
0000014 330  NN2     vials                    Z99 
0000014 340  CC      and                      Z5 
0000014 350  NN2     syringes                 O2 
0000014 351  ,       ,                        
0000014 360  CC      and                      Z5 
0000014 370  NN1     production               A1.1.1 A10+ K4 K3 Q4.3 
0000014 380  IO      of                       Z5 
0000014 390  JJ      microbial-derived        Z99 
0000014 400  JJ      recombinant              Z99 
0000014 410  NN2     proteins                 O1 
0000014 420  CC      and                      Z5 
0000014 430  NN1     plasmid                  Z99 
0000014 440  NN1     DNA                      B1 
0000014 441  .       .                        
0000014 442  -----   -----                    
0000014 450  II31    In                       S5+[i26.3.1 A2.2[i26.3.1 Z5 
0000014 460  II32    conjunction              S5+[i26.3.2 A2.2[i26.3.2 
0000014 470  II33    with                     S5+[i26.3.3 A2.2[i26.3.3 
0000014 480  DD2     these                    Z8 Z5 
0000014 490  VVG@    manufacturing            A1.1.1 
0000014 500  NN2     operations               A1.1.1 B3 G3 
0000014 501  ,       ,                        
0000014 510  NP1     Althea                   Z99 
0000014 520  NN2     Technologies             Y1 
0000014 530  VVZ@    offers                   A9- Q2.2 
0000014 540  JJ      comprehensive            A1.8+ P1 
0000014 550  NN1     development              A2.1+ A5.1+/A2.1 H1 
0000014 560  NN2     services                 S8+ S7.1- A1.1.1 S9 G3@ G2.1@ M3/M7@ 
0000014 570  II      including                A1.8+ 
0000014 571  :       :                        
0000014 580  RL      upstream                 M6 
0000014 590  CC      and                      Z5 
0000014 600  JJ      downstream               N3.3++ 
0000014 610  NN1     process                  A1.1.1 X4.2 
0000014 620  NN1     development              A2.1+ A5.1+/A2.1 H1 
0000014 621  ,       ,                        
0000014 630  JJ      analytical               X2.4 
0000014 640  NN1     development              A2.1+ A5.1+/A2.1 H1 
0000014 641  ,       ,                        
0000014 650  NN1     lyophilization           Z99 
0000014 660  NN1     cycle                    M3fn N6 B1 
0000014 661  ,       ,                        
0000014 670  JJ      complex                  A12- 
0000014 680  NN1     formulation              G1.1/X7 Y1 N2 
0000014 681  ,       ,                        
0000014 690  NN1     product                  O2 A1.1.1 A2.2 N2% 
0000014 700  NN1     release                  A1.7- A9- I2.2 K3 Q4 E6+ 
0000014 710  CC      and                      Z5 
0000014 720  JJ      ICH-compliant            Z99 
0000014 730  NN1     stability                A2.1- 
0000014 740  NN1     testing                  P1 B3 X2.4 A12- 
0000014 741  .       .                        
0000014 742  -----   -----                    
0000014 750  NN1     Althea                   Z99 
0000014 760  NN2     Technologies             Y1 
0000014 761  GE      '                        Z5 
0000014 770  NN1     formulation              G1.1/X7 Y1 N2 
0000014 780  NN1     technology               Y1 
0000014 790  NN1     platform                 M3/M7 M4/H1 H5 X7+ Y2 
0000014 800  VVZ     includes                 A1.8+ 
0000014 810  NP1     Crystalomics             Z99 
0000014 811  ,       ,                        
0000014 820  AT1     a                        Z5 
0000014 830  JJ      proprietary              A9+ 
0000014 840  NN1     technology               Y1 
0000014 850  CST     that                     Z8 Z5 
0000014 860  VVZ@    offers                   A9- Q2.2 
0000014 870  AT1     a                        Z5 
0000014 880  NN1     formulation              G1.1/X7 Y1 N2 
0000014 890  NN1     solution                 X4.2 O1.2 
0000014 900  IF      for                      Z5 
0000014 910  JJ      large                    N3.2+ N5+ A11.1+ 
0000014 920  NN1     molecule                 O1 
0000014 930  NN2     products                 O2 A1.1.1 A2.2 N2% 
0000014 940  CST     that                     Z8 Z5 
0000014 950  VM      must                     S6+ A7+ 
0000014 960  VBI     be                       Z5 A3+ 
0000014 970  VVN     delivered                M2 Q2.1 X9.2+ B3 S9% 
0000014 980  II      at                       Z5 
0000014 990  JJ      high                     N3.7+ N5+ A11.1+ S7.1+ A5.1+ T3- X3.2 G2.2+ E4.1+ I1.3+ F3 O4.2- O4.6+ S9 
0000014 000  NN2     concentrations           X5.1+ N5+ I2.2% O1.2 
0000014 010  CC      or                       Z5 
0000014 020  RG@     as                       A13 
0000014 030  JJ      sustained                T2++ A2.2 S8+ A9+ A1.1.1 B1 
0000014 040  NN1     release                  A1.7- A9- I2.2 K3 Q4 E6+ 
0000014 050  NN2     formulations             G1.1/X7 Y1 N2 
0000014 051  .       .                        
0000014 052  -----   -----                    
0000014 060  IF      For                      Z5 
0000014 070  DAR     more                     N5++ 
0000014 080  NN1     information              X2.2+ 
0000014 081  ,       ,                        
0000014 090  VV0     visit                    S1.1.1 M1 
0000014 100  NNU     www.altheatech.com       N3.3 N3.7 
0000014 101  .       .                        
0000015 001  -----   -----                    
0000016 010  NN1     SOURCE                   T2+ Q1.1 X2.2 W3/M4 
0000016 020  NP1     Ajinomoto                Z1mf[i27.2.1 Z3c[i27.2.1 
0000016 030  NP1     Althea                   Z1mf[i27.2.2 Z3c[i27.2.2 
0000016 031  ,       ,                        
0000016 040  JJ      Inc                      I2.1 
0000016 041  .       .                        
0000019 001  NULL    **8;57;text              
